BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28:267-275. [PMID: 21517953 DOI: 10.1111/j.1525-1470.2011.01421.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Madan N, Arnon R, Arnon R. Evaluation of cardiac manifestations in pediatric liver transplant candidates: Cardiac evaluation children pre-liver transplant. Pediatric Transplantation 2012;16:318-28. [DOI: 10.1111/j.1399-3046.2012.01667.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Gan L, Ni S, Tan Q, Wang H. A Retrospective Study of Propranolol Therapy in 109 Infants with Infantile Hemangioma. Pediatr Dermatol 2013;30:270-2. [DOI: 10.1111/pde.12046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
3 Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017;390:85-94. [PMID: 28089471 DOI: 10.1016/S0140-6736(16)00645-0] [Cited by in Crossref: 156] [Cited by in F6Publishing: 50] [Article Influence: 31.2] [Reference Citation Analysis]
4 Thompson PA, Chintagumpala M. Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med. 2012;17:216-221. [PMID: 22595862 DOI: 10.1016/j.siny.2012.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Li K, Wang Z, Liu Y, Yao W, Gong Y, Xiao X. Fine clinical differences between patients with multifocal and diffuse hepatic hemangiomas. Journal of Pediatric Surgery 2016;51:2086-90. [DOI: 10.1016/j.jpedsurg.2016.09.045] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ferrandiz L, Toledo-Pastrana T, Moreno-Ramirez D, Bardallo-Cruzado L, Perez-Bertolez S, Luna-Lagares S, Rios-Martin JJ. Diffuse neonatal hemangiomatosis with partial response to propranolol. Int J Dermatol. 2014;53:e247-e250. [PMID: 23834677 DOI: 10.1111/ijd.12155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Pride HB, Tollefson M, Silverman R. What's new in pediatric dermatology? Journal of the American Academy of Dermatology 2013;68:899.e1-899.e11. [DOI: 10.1016/j.jaad.2013.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Tal R, Dotan M, Lorber A. Approach to haemangiomatosis causing congestive heart failure. Acta Paediatr 2016;105:600-4. [DOI: 10.1111/apa.13359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Wildgruber M, Sadick M, Müller-Wille R, Wohlgemuth WA. Vascular tumors in infants and adolescents. Insights Imaging 2019;10:30. [PMID: 30868300 DOI: 10.1186/s13244-019-0718-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
10 Rialon KL, Murillo R, Fevurly RD, Kulungowski AM, Christison-Lagay ER, Zurakowski D, Kozakewich HP, Alomari AI, Fishman SJ. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2015;50:837-841. [PMID: 25783331 DOI: 10.1016/j.jpedsurg.2014.09.056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
11 Rubinstein JC, Christison-lagay ER. Successful treatment of visceral infantile hemangioma of the omentum and mesentery with propranolol. Journal of Pediatric Surgery Case Reports 2014;2:302-4. [DOI: 10.1016/j.epsc.2014.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Hogeling M. Propranolol for Infantile Hemangiomas: A Review. Curr Derm Rep 2012;1:179-85. [DOI: 10.1007/s13671-012-0026-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Briones M, Adams D. Neonatal Vascular Tumors. Clin Perinatol 2021;48:181-98. [PMID: 33583504 DOI: 10.1016/j.clp.2020.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Baena-Gómez MA, Priego Ruiz MP, Mateos González E, Peña Rosa MJ, Muñoz Sánchez R. [Hepatic hemangiomas: Spectacular response to treatment with propranolol]. An Pediatr (Barc) 2015;83:435-7. [PMID: 26122492 DOI: 10.1016/j.anpedi.2015.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatric Health Med Ther 2017;8:107-16. [PMID: 29388636 DOI: 10.2147/PHMT.S115528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Jahnke MN. Vascular Lesions. Pediatr Ann 2016;45:e299-305. [PMID: 27517358 DOI: 10.3928/19382359-20160720-08] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Weber Pasa M, Selbach Scheffel R, Borsatto Zanella A, Maia AL, Dora JM. Consumptive Hypothyroidism: Case Report of Hepatic Hemangioendotheliomas Successfully Treated with Vincristine and Systematic Review of the Syndrome. Eur Thyroid J 2017;6:321-7. [PMID: 29234626 DOI: 10.1159/000481253] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
18 Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78:44-57. [PMID: 24033819 DOI: 10.1111/bcp.12235] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
19 Mcguire A, Fernandez-pineda I, Fishman SJ, Dickie BH. Pediatric hepatic vascular tumors. Seminars in Pediatric Surgery 2020;29:150970. [DOI: 10.1016/j.sempedsurg.2020.150970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Schmalz MJ, Radhakrishnan K. Vascular anomalies associated with hepatic shunting. World J Gastroenterol 2020; 26(42): 6582-6598 [PMID: 33268948 DOI: 10.3748/wjg.v26.i42.6582] [Reference Citation Analysis]
21 Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, Wang Q, Lu G, Yang L. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744. [PMID: 27530723 DOI: 10.1038/srep31744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
22 Baena-gómez M, Priego Ruiz M, González E, Peña Rosa M, Muñoz Sánchez R. Hepatic hemangiomas: Spectacular response to treatment with propranolol. Anales de Pediatría (English Edition) 2015;83:435-7. [DOI: 10.1016/j.anpede.2015.10.016] [Reference Citation Analysis]
23 Schupp CJ, Kleber JB, Günther P, Holland-Cunz S. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol 2011;28:640-4. [PMID: 21995836 DOI: 10.1111/j.1525-1470.2011.01569.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
24 Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140. [PMID: 23266923 DOI: 10.1542/peds.2012-1691] [Cited by in Crossref: 304] [Cited by in F6Publishing: 219] [Article Influence: 30.4] [Reference Citation Analysis]
25 Bosemani T, Puttgen KB, Huisman TA, Tekes A. Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature. Eur J Pediatr. 2012;171:1023-1028. [PMID: 22234480 DOI: 10.1007/s00431-011-1671-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
26 Funk T, Prok L, Brown LD, Bruckner AL. Multifocal Vascular Tumors and Fetal Hydrops. The Journal of Pediatrics 2014;164:1214-8. [DOI: 10.1016/j.jpeds.2013.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Campbell V, Beckett R, Abid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol 2018;10:294-8. [PMID: 29537380 DOI: 10.4274/jcrpe.4865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
28 Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 2020;179:1-8. [DOI: 10.1007/s00431-019-03504-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Harter N, Mancini AJ. Diagnosis and Management of Infantile Hemangiomas in the Neonate. Pediatr Clin North Am. 2019;66:437-459. [PMID: 30819347 DOI: 10.1016/j.pcl.2018.12.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
30 Menapace D, Mitkov M, Towbin R, Hogeling M. The changing face of complicated infantile hemangioma treatment. Pediatr Radiol 2016;46:1494-506. [PMID: 27450406 DOI: 10.1007/s00247-016-3643-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]